Nomura Asset Management CO LTD Kal Vista Pharmaceuticals, Inc. Transaction History

Nomura Asset Management CO LTD

11 transactions

Quarter	Operation	Price Per share	shares change
Q2 2021 Aug 06, 2021	SELL	$23.12 - $29.91 $0 - $0	0 Closed
Q1 2021 Jan 10, 2025	BUY	$14.69 - $42.57 $0 - $0	0 New
Q1 2021 May 14, 2021	BUY	$14.69 - $42.57 $0 - $0	0 New
Q4 2020 Jan 10, 2025	BUY	$12.88 - $19.47 $0 - $0	0 New
Q4 2020 Feb 12, 2021	BUY	$12.88 - $19.47 $0 - $0	0 New
Q3 2020 Nov 12, 2020	BUY	$9.83 - $13.99 $0 - $0	0 New
Q2 2020 Aug 13, 2020	BUY	$6.75 - $12.89 $0 - $0	0 New
Q1 2020 May 14, 2020	BUY	$5.8 - $18.56 $0 - $0	0 New
Q4 2019 Feb 13, 2020	BUY	$10.31 - $17.81 $0 - $0	0 New
Q3 2019 Nov 13, 2019	BUY	$11.6 - $21.67 $0 - $0	0 New
Q2 2019 Aug 13, 2019	BUY	$18.44 - $30.89 $0 - $0	0 New

135

52M

551K

98K

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $240M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

Stay updated on Nomura Asset Management CO LTD with notifications on news.